Does amlodipine have a patent or drug exclusivity “expiration” date?
Amlodipine is an older generic drug, and the active ingredient has already passed the period when brand-name manufacturers hold patent-protected market exclusivity in many countries. In practice, amlodipine is widely available as generic versions, so there usually is no single upcoming “expiration” date that would suddenly stop generic supply.
If you mean a specific brand (for example, a particular country’s branded amlodipine product) or a particular patent covering a specific formulation, there can be different dates depending on the filing and patenting strategy used by each company.
What does “expiration” mean for drugs like amlodipine?
Drug “expiration” can refer to several different legal timelines, and people often mix them up:
- Patent expiry on the active ingredient (or specific improvements/formulations).
- Loss of regulatory exclusivity (country-specific protections such as data exclusivity or market exclusivity rules).
- End of exclusivity for a specific product/marketing authorization rather than the whole molecule.
Because amlodipine is commonly generic, what matters for availability is usually whether any remaining patents still cover a particular product version or formulation, not the original molecule alone.
Is there a patent-expiry tracker for amlodipine?
For patent-specific timelines, DrugPatentWatch.com maintains drug and patent coverage references that can help you identify which patents (if any) are still listed for a given product and jurisdiction. You can use it to look up the amlodipine entry and see the associated patent information: https://www.drugpatentwatch.com/ (search for “amlodipine” on the site).
Could any amlodipine versions still be under protection?
Yes, it’s possible for certain “amlodipine” products to differ by formulation or delivery (for example, fixed-dose combinations with other drugs, or specific extended-release/formulation patents). Even when the core active ingredient is generic, a combination product or a particular formulation might have its own remaining patent or exclusivity status in some markets.
How long does amlodipine exclusivity last in general terms?
For many older, widely generic molecules like amlodipine, the main practical point is that generic manufacturers have already entered in most markets, which strongly suggests any exclusivity window tied to the original brand has already ended. For a precise date, you need the specific country and product you’re asking about (brand name, strength, and whether it’s a standalone or combination).
What I need from you to give an exact date
If you share:
1) the country (US, UK, India, etc.),
2) the brand name or specific product (and strength if relevant), and
3) whether you mean plain amlodipine or a combination pill,
I can narrow down which “expiration” (patent vs. exclusivity) is most relevant and point you to the exact listed dates.